As of 2025-05-25, the EV/EBITDA ratio of Treace Medical Concepts Inc (TMCI) is -9.54. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. TMCI's latest enterprise value is 409.85 mil USD. TMCI's TTM EBITDA according to its financial statements is -42.95 mil USD. Dividing these 2 quantities gives us the above TMCI EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 17.2x - 24.0x | 20.9x |
| Forward P/E multiples | 22.3x - 26.8x | 23.6x |
| Fair Price | (15.87) - (17.00) | (15.82) |
| Upside | -369.8% - -389.1% | -369.0% |
| Date | EV/EBITDA |
| 2025-05-21 | -10.14 |
| 2025-05-20 | -10.73 |
| 2025-05-19 | -10.79 |
| 2025-05-16 | -10.77 |
| 2025-05-15 | -10.82 |
| 2025-05-14 | -10.77 |
| 2025-05-13 | -11.15 |
| 2025-05-12 | -11.47 |
| 2025-05-09 | -10.92 |
| 2025-05-08 | -11.97 |
| 2025-05-07 | -11.47 |
| 2025-05-06 | -11.74 |
| 2025-05-05 | -11.65 |
| 2025-05-02 | -11.56 |
| 2025-05-01 | -11.68 |
| 2025-04-30 | -11.30 |
| 2025-04-29 | -11.26 |
| 2025-04-28 | -11.04 |
| 2025-04-25 | -10.77 |
| 2025-04-24 | -10.68 |
| 2025-04-23 | -10.32 |
| 2025-04-22 | -10.10 |
| 2025-04-21 | -10.36 |
| 2025-04-17 | -10.38 |
| 2025-04-16 | -10.48 |
| 2025-04-15 | -10.63 |
| 2025-04-14 | -10.83 |
| 2025-04-11 | -10.79 |
| 2025-04-10 | -11.17 |
| 2025-04-09 | -11.78 |
| 2025-04-08 | -11.33 |
| 2025-04-07 | -12.08 |
| 2025-04-04 | -12.28 |
| 2025-04-03 | -12.40 |
| 2025-04-02 | -13.11 |
| 2025-04-01 | -12.87 |
| 2025-03-31 | -13.22 |
| 2025-03-28 | -13.31 |
| 2025-03-27 | -13.19 |
| 2025-03-26 | -13.50 |
| 2025-03-25 | -13.38 |
| 2025-03-24 | -13.66 |
| 2025-03-21 | -13.01 |
| 2025-03-20 | -12.97 |
| 2025-03-19 | -12.95 |
| 2025-03-18 | -13.28 |
| 2025-03-17 | -12.60 |
| 2025-03-14 | -12.57 |
| 2025-03-13 | -12.56 |
| 2025-03-12 | -12.91 |